Page 25 - DIY Investor Magazine | Issue 33
P. 25
The AIC Healthcare and Biotechnology sector, constitutes seven trusts, offering a variety of exposures and approaches.
All of these trusts should be long term beneficiaries of the dynamics we describe above, but as we illustrate, several now have significant exposure to mid and small-cap opportunities.
In the context of the equity market pull-back this year
was that even before the tragic events in Ukraine started unfolding, Healthcare and Biotechnology indices had been underperforming. Healthcare is one of the places where innovation rarely takes a day off.
With global populations ageing and getting richer, one of the constants in life is rising global spending on healthcare. If a new wave of M&A commences, this could start a new period of outperformance for the sector over global equities.
Disclaimer
This is not substantive investment research or a research recommendation, as it does not constitute substantive research or analysis. This material should be considered as general market commentary.
25
DIY Investor Magazine ยท Apr 2022
